Prophylaxis of Venous Thromboembolism after Hospital Discharge in Internal Medicine: Findings from the Observational FADOI-NoTEVole Study

Thromb Haemost. 2019 Dec;119(12):2043-2052. doi: 10.1055/s-0039-1697661. Epub 2019 Oct 21.

Abstract

Background and aim: Post-discharge prophylaxis for venous thromboembolism (VTE) is a challenging issue in patients hospitalised in Internal Medicine Units (IMUs). The aim of this study was to evaluate the frequency and the factors associated with post-discharge prophylaxis for VTE in IMUs.

Methods: Multi-centre, retrospective study including consecutive patients who were admitted for any cause and discharged from an IMU.

Results: Overall, 3,740 patients (mean age 74.1 ± 15.7 years) were included in the study at 38 IMUs in Italy. At discharge, the percentage of patients receiving pharmacological thromboprophylaxis was 16.0% (20.1% after excluding patients treated with anticoagulants for indications other than VTE prophylaxis). At multivariable analysis, history of ischaemic stroke, hypomobility ≥ 7 days, central venous catheter, ≥ 10 versus ≤ 5 days of hospital stay, use of corticosteroids, cancer, history of falls, availability of a caregiver, infections and age were significantly associated with thromboprophylaxis, while an inverse correlation was observed with concomitant anti-platelet drugs and platelet count < 70,000/mm3. Patients with a Padua Prediction Score ≥ 4 versus < 4 and with an IMPROVE bleeding score ≥ 7 versus < 7 more frequently received prophylaxis at discharge (31.2% vs. 10.6%, p < 0.0001, and 25.7% vs. 19.6%, p = 0.028, respectively).

Conclusion: In this study, one in five patients discharged from an Italian IMU received prophylaxis for VTE. The perceived thrombotic risk is significantly related to the use of prophylaxis.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Accidental Falls
  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use*
  • Caregivers
  • Catheterization, Central Venous
  • Female
  • Hospitalization
  • Humans
  • Internal Medicine
  • Italy
  • Length of Stay
  • Male
  • Middle Aged
  • Neoplasms / complications
  • Patient Discharge*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Platelet Count
  • Retrospective Studies
  • Risk Factors
  • Stroke / complications
  • Venous Thromboembolism / prevention & control*
  • Young Adult

Substances

  • Adrenal Cortex Hormones
  • Anticoagulants
  • Platelet Aggregation Inhibitors